INFU(INFU)
INFU
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $145M | $156M | $165M |
| Low | $144M | $155M | $164M |
| High | $146M | $157M | $167M |
| EBITDA Avg | $27M | $29M | $31M |
| Low | $27M | $29M | $31M |
| High | $28M | $30M | $32M |
| EBIT Avg | $23M | $24M | $26M |
| Low | $22M | $24M | $26M |
| High | $23M | $25M | $26M |
| Net Income Avg | $9M | $11M | — |
| Low | $9M | $11M | — |
| High | $9M | $12M | — |
| EPS Avg | $0.42 | $0.55 | — |
| Low | $0.42 | $0.54 | — |
| High | $0.43 | $0.55 | — |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $37M | $37M | $36M | $39M | $40M | $41M |
| Low | $37M | $37M | $36M | $39M | $40M | $41M |
| High | $37M | $38M | $37M | $40M | $41M | $41M |
| EBITDA Avg | $7M | $7M | $7M | $7M | $8M | $8M |
| Low | $7M | $7M | $7M | $7M | $8M | $8M |
| High | $7M | $7M | $7M | $7M | $8M | $8M |
| EBIT Avg | $6M | $6M | $6M | $6M | $6M | $6M |
| Low | $6M | $6M | $6M | $6M | $6M | $6M |
| High | $6M | $6M | $6M | $6M | $6M | $6M |
| Net Income Avg | $3M | $3M | $1M | $3M | $3M | $4M |
| Low | $3M | $3M | $1M | $3M | $3M | $4M |
| High | $3M | $3M | $1M | $3M | $4M | $4M |
| EPS Avg | $0.13 | $0.14 | $0.06 | $0.14 | $0.17 | $0.17 |
| Low | $0.13 | $0.14 | $0.06 | $0.14 | $0.17 | $0.17 |
| High | $0.13 | $0.14 | $0.06 | $0.14 | $0.17 | $0.17 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |